MAHIR SHAH: Open Payments
NPI 1083709182 · FORT MILL, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,063 in 111 payments from 17 companies in 2025. Trend: 2023 $1,251 · 2024 $1,657 · 2025 $2,063
Food & beverage: $2,063
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $394 |
| ABBVIE INC. | 18 | $291 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $244 |
| Otsuka America Pharmaceutical, Inc. | 13 | $187 |
| E.R. Squibb & Sons, L.L.C. | 13 | $163 |
| Lundbeck LLC | 9 | $159 |
| Supernus Pharmaceuticals, Inc. | 6 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $104 |
| Collegium Pharmaceutical, Inc. | 5 | $97 |
| Vanda Pharmaceuticals Inc. | 3 | $55 |
Products named: Auvelity, REXULTI, VRAYLAR, TRINTELLIX, COBENFY, Qelbree, CAPLYTA, Jornay PM.
Industry payments across SC — which companies pay providers there.
